|Articles|October 16, 2020
- Applied Clinical Trials-10-01-2020
- Volume 29
- Issue 10
Applied Clinical Trials, October 2020 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials September 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Better Cardiac Safety Trialsover 5 years ago
Shifting Perspectives on Site Networks to Create Positive Changeover 5 years ago
News Notes (October)over 5 years ago
Europe's COVID Vaccine Bids Still Veiled in Secrecyover 5 years ago
COVID Advances Clinical Trial Transparencyover 5 years ago
The Future of Remote Trialsover 5 years ago
COVID-19 Highlights Need for More Diversity in TrialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
5